IFS, the leading provider of Industrial AI software, today announced the completion of its acquisition of Softeon, providing enterprises across manufacturing, logistics and retail access to a new category of supply chain technology. Operating as IFS Softeon, the move brings together IFS’s powerful Industrial AI capabilities with Softeon’s 20+ years of tier-1 warehouse management software […] The post IFS Completes Acquisition of Softeon, Creating a Powerhouse in End-to-End Supply Chain Intelligence appeared first on Web-Release.

    Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.